Kalaris Therapeutics (KLRS) Leases (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Leases data on record, last reported at $9.5 million in Q3 2020.
- For Q3 2020, Leases rose 50.38% year-over-year to $9.5 million; the TTM value through Sep 2020 reached $9.5 million, up 50.38%, while the annual FY2019 figure was $11.8 million, N/A changed from the prior year.
- Leases reached $9.5 million in Q3 2020 per KLRS's latest filing, down from $10.2 million in the prior quarter.
- Across five years, Leases topped out at $11.8 million in Q4 2019 and bottomed at $6.3 million in Q3 2019.